Long-term outcomes for patients with cardiac arrhythmias
Longterm Outcome and Predictors for Recurrence After Medical and Interventional Treatment of Arrhythmias At the University Heart Center Hamburg
This study looks at how well treatments for heart rhythm problems work over time and what factors might affect their success for patients with conditions like atrial fibrillation and ventricular tachycardia.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf Academic / other |
| Locations | 1 site (Hamburg) |
| Trial ID | NCT05521451 on ClinicalTrials.gov |
What this trial studies
The TRUST study is a prospective cohort study that focuses on patients with cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia, treated at the University Heart Center Hamburg. It aims to collect comprehensive clinical, procedural, and outcome data to better understand the long-term effects and predictors of recurrence after treatment. The study will utilize systematic biobanking and digital capture of clinical information to enhance patient phenotyping and follow-up. This approach allows for a thorough analysis of the disease burden associated with arrhythmias in an aging population.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with diagnosed cardiac arrhythmias or those at high risk for developing them.
Not a fit: Patients who are not proficient in the German language or those unable to cooperate due to physical or psychological issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies and better management of cardiac arrhythmias, ultimately enhancing patient outcomes.
How similar studies have performed: Other studies focusing on the long-term outcomes of cardiac arrhythmias have shown promise, indicating that this approach could yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cardiac arrhythmia, including congenital cardiac arrhythmia diagnosed at baseline or high risk for cardiac arrhythmia * Age ≥ 18 years * Written informed consent * Ability to provide written informed consent in accordance with Good Clinical Practice and local legislation Exclusion Criteria: * Insufficient knowledge of the German language to understand study documents and interview without translation * Physical or psychological incapability to cooperate in the investigation
Where this trial is running
Hamburg
- University Hospital Hamburg-Eppendorf, University Heart and Vascular Center — Hamburg, Germany (Recruiting)
Study contacts
- Principal investigator: Paulus Kirchhof, MD — Universitätsklinikum Hamburg-Eppendorf
- Study coordinator: Julius Obergassel, MD
- Email: trust@uke.de
- Phone: +49 (40) 7410 - 58320
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.